Scientists hunt clues to stop lymphoma treatment resistance
NCT ID NCT07385612
Summary
This French study aims to understand why some B-cell lymphomas become resistant to chemotherapy and newer treatments. Researchers will collect blood and tissue samples from 80 patients before and after their treatment courses. By studying these samples, they hope to identify biological markers that predict treatment failure and develop better laboratory models for future drug testing.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MATURE B-CELL LYMPHOIDS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
CHU Nantes
Nantes, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.